← Back to Search

Genetics ADvISER Decision Aid for Cancer

N/A
Waitlist Available
Led By Yvonne Bombard, PhD
Research Sponsored by Unity Health Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at immediately after baseline/ post intervention, 2 months and 4 months.
Awards & highlights

Summary

This trial tests Genetics ADvISER, a digital tool that helps adult cancer patients understand and choose which genetic test results they want to receive. It aims to reduce confusion and anxiety by providing clear information and support.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at immediately after baseline/ post intervention, 2 months and 4 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at immediately after baseline/ post intervention, 2 months and 4 months. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Decisional Conflict Scale (DCS)
Secondary study objectives
Acceptability
Hospital Anxiety and Depression Scale (HADS)
Knowledge
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Genetics ADviSER Decision Aid Plus Standard Genetic CounsellingExperimental Treatment1 Intervention
Participants in the intervention arm will use the Genetics ADviSER to learn about genomic sequencing and to select which results they would like to receive from genomics sequencing results. After using the Genetics ADviSER decision aid they will speak with genetic counselor to discuss their choices and to finalized their selection.
Group II: Standard Genetic Counselling OnlyActive Control1 Intervention
Participants will speak with a genetic counsellor over the phone to learn about genomic sequencing and select which incidental findings they would like to receive from genomic sequencing.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Genetics ADvISER Decision Aid Plus Standard Genetic Counselling
2021
N/A
~140

Find a Location

Who is running the clinical trial?

Unity Health TorontoLead Sponsor
554 Previous Clinical Trials
454,158 Total Patients Enrolled
Yvonne Bombard, PhDPrincipal InvestigatorSt. Michael's Hospital and University of Toronto
3 Previous Clinical Trials
592 Total Patients Enrolled

Media Library

Genetics ADvISER Decision Aid Clinical Trial Eligibility Overview. Trial Name: NCT04725565 — N/A
Cancer Research Study Groups: Standard Genetic Counselling Only, Genetics ADviSER Decision Aid Plus Standard Genetic Counselling
Cancer Clinical Trial 2023: Genetics ADvISER Decision Aid Highlights & Side Effects. Trial Name: NCT04725565 — N/A
Genetics ADvISER Decision Aid 2023 Treatment Timeline for Medical Study. Trial Name: NCT04725565 — N/A
~32 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top